Skip to main content

Table 3 Age-adjusted anti-HEV-IgG seroprevalence in the study population and control group characterized in Table 1

From: Hepatitis E virus as a trigger for Guillain-Barré syndrome

Age group GBS: n(%) Healthy controls:
n(%)
P valuea
18–19 0/3 (0) 0/2 (0) 1
20–29 1/12 (8) 18/149 (12) 1
30–39 2/15 (13) 7/45 (16) 1
40–49 9/20 (45) 4/20 (20) .176
50–59 15/34 (44) 10/31 (32) .445
60–69 19/35 (54) 4/9 (44) .716
70–79 16/32 (50) 1/2 (50) 1
80–89 5/12 (42) 1/5 (20) .600
  1. aStatistical analysis: two-tailed Fisher’s exact Test